201 related articles for article (PubMed ID: 36549555)
1. Development of a porous layer-by-layer microsphere with branched aliphatic hydrocarbon porogens.
Shahjin F; Patel M; Hasan M; Cohen JD; Islam F; Ashaduzzaman M; Nayan MU; Subramaniam M; Zhou Y; Andreu I; Gendelman HE; Kevadiya BD
Nanomedicine; 2023 Feb; 48():102644. PubMed ID: 36549555
[TBL] [Abstract][Full Text] [Related]
2. Fabrication of covered porous PLGA microspheres using hydrogen peroxide for controlled drug delivery and regenerative medicine.
Bae SE; Son JS; Park K; Han DK
J Control Release; 2009 Jan; 133(1):37-43. PubMed ID: 18838089
[TBL] [Abstract][Full Text] [Related]
3. Biodegradable recombinant human erythropoietin loaded microspheres prepared from linear and star-branched block copolymers: influence of encapsulation technique and polymer composition on particle characteristics.
Pistel KF; Bittner B; Koll H; Winter G; Kissel T
J Control Release; 1999 Jun; 59(3):309-25. PubMed ID: 10332063
[TBL] [Abstract][Full Text] [Related]
4. Hydrophilic versus hydrophobic porogens for engineering of poly(lactide-co-glycolide) microparticles containing risedronate sodium.
Nasr M; Awad GA; Mansour S; Al Shamy A; Mortada ND
Pharm Dev Technol; 2013; 18(5):1078-88. PubMed ID: 22656315
[TBL] [Abstract][Full Text] [Related]
5. Mechanical properties and dual drug delivery application of poly(lactic-co-glycolic acid) scaffolds fabricated with a poly(β-amino ester) porogen.
Clark A; Milbrandt TA; Hilt JZ; Puleo DA
Acta Biomater; 2014 May; 10(5):2125-32. PubMed ID: 24424269
[TBL] [Abstract][Full Text] [Related]
6. A novel strategy for the preparation of porous microspheres and its application in peptide drug loading.
Wei Y; Wang Y; Zhang H; Zhou W; Ma G
J Colloid Interface Sci; 2016 Sep; 478():46-53. PubMed ID: 27285778
[TBL] [Abstract][Full Text] [Related]
7. Preparation and characterization of poly-(D,L-lactide-co-glycolide) and poly-(L-lactic acid) microspheres with entrapped pneumotropic bacterial antigens.
Kofler N; Ruedl C; Klima J; Recheis H; Böck G; Wick G; Wolf H
J Immunol Methods; 1996 Jun; 192(1-2):25-35. PubMed ID: 8699019
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the initial burst release of a model peptide from poly(D,L-lactide-co-glycolide) microspheres.
Wang J; Wang BM; Schwendeman SP
J Control Release; 2002 Aug; 82(2-3):289-307. PubMed ID: 12175744
[TBL] [Abstract][Full Text] [Related]
9. Mechanistic evaluation of the glucose-induced reduction in initial burst release of octreotide acetate from poly(D,L-lactide-co-glycolide) microspheres.
Wang J; Wang BM; Schwendeman SP
Biomaterials; 2004 May; 25(10):1919-27. PubMed ID: 14738856
[TBL] [Abstract][Full Text] [Related]
10. Structured Biodegradable Polymeric Microparticles for Drug Delivery Produced Using Flow Focusing Glass Microfluidic Devices.
Ekanem EE; Nabavi SA; Vladisavljević GT; Gu S
ACS Appl Mater Interfaces; 2015 Oct; 7(41):23132-43. PubMed ID: 26423218
[TBL] [Abstract][Full Text] [Related]
11. Bioactive poly(ε-caprolactone) microspheres with tunable open pores as microcarriers for tissue regeneration.
Zhou A; Ye Z; Zhou Y; Tan WS
J Biomater Appl; 2019 Apr; 33(9):1242-1251. PubMed ID: 30782056
[TBL] [Abstract][Full Text] [Related]
12. Solvent/non-solvent sintering: a novel route to create porous microsphere scaffolds for tissue regeneration.
Brown JL; Nair LS; Laurencin CT
J Biomed Mater Res B Appl Biomater; 2008 Aug; 86(2):396-406. PubMed ID: 18161819
[TBL] [Abstract][Full Text] [Related]
13. Preparation of cylinder-shaped porous sponges of poly(L-lactic acid), poly(DL-lactic-co-glycolic acid), and poly(ε-caprolactone).
He X; Kawazoe N; Chen G
Biomed Res Int; 2014; 2014():106082. PubMed ID: 24719843
[TBL] [Abstract][Full Text] [Related]
14. Effect of preparation temperature on the characteristics and release profiles of PLGA microspheres containing protein fabricated by double-emulsion solvent extraction/evaporation method.
Yang YY; Chia HH; Chung TS
J Control Release; 2000 Oct; 69(1):81-96. PubMed ID: 11018548
[TBL] [Abstract][Full Text] [Related]
15. Determinants of release rate of tetanus vaccine from polyester microspheres.
Alonso MJ; Cohen S; Park TG; Gupta RK; Siber GR; Langer R
Pharm Res; 1993 Jul; 10(7):945-53. PubMed ID: 8378256
[TBL] [Abstract][Full Text] [Related]
16. Poly(lactide-co-glycolide) microspheres for the controlled release of oligonucleotide/polyethylenimine complexes.
De Rosa G; Quaglia F; La Rotonda MI; Appel M; Alphandary H; Fattal E
J Pharm Sci; 2002 Mar; 91(3):790-9. PubMed ID: 11920765
[TBL] [Abstract][Full Text] [Related]
17. Biodegradable bromocryptine mesylate microspheres prepared by a solvent evaporation technique. I: Evaluation of formulation variables on microspheres characteristics for brain delivery.
Arica B; Kaş HS; Orman MN; Hincal AA
J Microencapsul; 2002; 19(4):473-84. PubMed ID: 12396384
[TBL] [Abstract][Full Text] [Related]
18. Controlled drug release from a novel injectable biodegradable microsphere/scaffold composite based on poly(propylene fumarate).
Kempen DH; Lu L; Kim C; Zhu X; Dhert WJ; Currier BL; Yaszemski MJ
J Biomed Mater Res A; 2006 Apr; 77(1):103-11. PubMed ID: 16392139
[TBL] [Abstract][Full Text] [Related]
19. Protein encapsulation and release from poly(lactide-co-glycolide) microspheres: effect of the protein and polymer properties and of the co-encapsulation of surfactants.
Blanco D; Alonso MJ
Eur J Pharm Biopharm; 1998 May; 45(3):285-94. PubMed ID: 9653633
[TBL] [Abstract][Full Text] [Related]
20. Effect of polymer source on in vitro drug release from PLGA microspheres.
Wan B; Andhariya JV; Bao Q; Wang Y; Zou Y; Burgess DJ
Int J Pharm; 2021 Sep; 607():120907. PubMed ID: 34332059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
